Hydralazine: all 32 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Intravenous Labetalol Versus Hydralazine in PreeclampsiaRecruitingNCT06360601Phase 1/2
- Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsRecruitingNCT06218199Phase 4
- Blood Pressure After Endovascular Stroke Therapy-IICompletedNCT04116112Phase 2Results posted
- Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRDCompletedNCT02228408Phase 4Results posted
- Vasodilator Therapy for Heart Failure and Preserved Ejection FractionCompletedNCT01516346Phase 2Results posted
- Black Education and Treatment of Hypertension (BEAT HTN)CompletedNCT00661895Phase 4Results posted
- Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced HypertensionTerminatedNCT00607477Not applicableResults posted
- Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe PreeclampsiaCompletedNCT07572656Not applicable
- Effect of Hydralazine on Alzheimer's DiseaseCompletedNCT04842552Phase 3
- Blood Pressure Management in Stroke Following Endovascular TreatmentCompletedNCT04484350Phase 2
- Efficacy of Nifedipine Versus Hydralazine in Management of Severe Hypertension in PregnancyCompletedNCT04435210Not applicable
- Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease PatientsCompletedNCT03423810Early Phase 1
- Changes in Central Arterial Pressure When Comparing ACOG Hypertensive Urgency ProtocolsWithdrawnNCT02933593Not applicable
- Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical CancerWithdrawnNCT02446652Phase 3
- Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) StudyStatus unknownNCT02343393Phase 3
- The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial IITerminatedNCT02281838Phase 2
- Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular DegenerationStatus unknownNCT02127463Phase 2/3
- Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart FailureStatus unknownNCT01822808Phase 3
- Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular DegenerationTerminatedNCT01601483Phase 2/3
- A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human VolunteersCompletedNCT01587313Phase 1
- Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of PregnancyCompletedNCT01538875Phase 3
- Blood Pressure Reduction in Heart FailureCompletedNCT01255475Phase 2/3
- A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMDCompletedNCT01013376Phase 1
- Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure TrialCompletedNCT00963976Phase 2
- Hydralazine as Demethylating Agent in Breast CancerWithdrawnNCT00575978Phase 1/2
- Hydralazine as a Demethylating Agent in Rectal CancerWithdrawnNCT00575640Phase 1/2
- Hydralazine Valproate for Ovarian CancerStatus unknownNCT00533299Phase 3
- Hydralazine Valproate for Cervical CancerStatus unknownNCT00532818Phase 3
- A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid TumorsCompletedNCT00404508Phase 2
- Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical CancerCompletedNCT00404326Phase 2
- Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
- Heart and Blood Pressure Study: The Effect of Aortic Impedance on Myocardial RelaxationCompletedNCT00204984Not applicable